99 results on '"Muggia, Franco"'
Search Results
2. Superior vena cava syndrome and breast cancer: A case series highlighting a rare complication
3. Basal cell carcinoma after breast radiation: An uncommon disease with varying clinical presentations.
4. Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study
5. Sequential therapy with INCAGN01949 followed by ipilimumab and nivolumab in two patients with advanced ovarian carcinoma
6. Platinum compounds: Their continued impact on ovarian cancer treatment
7. Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis
8. Platinum type is key in determining degree of neuropathy
9. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
10. Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer
11. Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope
12. Targeting HER2 in ovarian and uterine cancers: Challenges and future directions
13. Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer
14. Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis
15. Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
16. Clinical Drug Development in 2012
17. Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study
18. In Memorium
19. The regulation of MASPIN expression in epithelial ovarian cancer: Association with p53 status, and MASPIN promoter methylation: A Gynecologic Oncology Group study
20. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
21. Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
22. A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study
23. Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study
24. Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
25. Pharmacodynamics of Tubulin and Tubulin-Binding Agents: Extending Their Potential Beyond Taxanes
26. Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
27. Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast Cancer
28. New and Emerging Intraperitoneal (IP) Drugs for Ovarian Cancer Treatment
29. More on intraperitoneal therapy
30. Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: An NYGOG and ECOG study
31. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study
32. Platinum coordination compounds in cancer chemotherapy
33. Liposomal anthracycline treatment for ovarian cancer
34. Relevance of chemotherapy dose and schedule to outcomes in ovarian cancer
35. Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials
36. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers
37. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
38. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study
39. A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer
40. Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
41. Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy
42. Use of Medroxyprogesterone Acetate in the Treatment of Müllerian Adenosarcoma: A Case Report
43. Neoadjuvant Chemotherapy with CPT-11 and Cisplatin Downstages Locally Advanced Gastric Cancer
44. De libris
45. CPT-11/Cisplatin neoadjuvant therapy downstages locally advanced gastric cancer
46. Doxil-Induced Radiation Recall: A Cause for False-Positive PET Scan Findings
47. Cisplatin–paclitaxel treatment for advanced ovarian cancer resulted in longer survival than cisplatin–cyclophosphamide
48. Phase II Study of Liposomal Doxorubicin in Advanced Gynecologic Cancers
49. Phase II randomized study of paclitaxel and paclitaxel + PSC 833 for advanced breast cancer
50. Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.